NVST — Envista Holdings Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1757073 ·
Last close
$23.95
Market Cap
$3.85B
52W High
$30.42
52W Low
$18.77
ADV30
2,689,483
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 730,500,000 | 407,000,000 | 80,300,000 | 53,700,000 | 5,597,100,000 | 1,125,600,000 | 2,520,800,000 |
| Mar 2026 | 705,500,000 | 390,100,000 | 66,200,000 | 38,700,000 | 5,578,000,000 | 1,082,800,000 | 2,498,500,000 |
| Dec 2025 | 750,600,000 | 410,600,000 | 93,000,000 | 32,900,000 | 5,679,000,000 | 1,211,700,000 | 2,572,700,000 |
| Sep 2025 | 669,900,000 | 370,200,000 | 57,500,000 | -30,300,000 | 5,642,500,000 | 1,133,900,000 | 2,554,300,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$302,600,000
Investing CF
$-108,400,000
Financing CF
$-173,200,000
CapEx
$-54,500,000
Dividends Paid
—
Buybacks
$-169,300,000
EPS Diluted TTM
$0.58
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-348,000,000
Inventory
$290,900,000
Receivables
$436,900,000
ST Investments
—
EBIT TTM
$269,500,000
Pretax Income TTM
$234,100,000
Interest Exp TTM
$35,400,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,856,499,968
EBITDA
$406,200,000
Free Cash Flow
$267,887,504
Enterprise Value
$4,566,182,400
Total Cash
$1,125,600,000
Total Debt
$1,588,000,000
Shares Out
160,617,709
Trailing EPS
$0.58
Book Value
$19.16
ROE
3.1%
ROA
3.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,719,500,000 | 235,800,000 | 47,000,000 | 5,679,000,000 | 2,572,700,000 | 3,106,300,000 | 275,700,000 |
| Dec 2024 | 2,510,600,000 | 137,200,000 | -1,118,600,000 | 5,350,500,000 | 2,415,700,000 | 2,934,800,000 | 336,500,000 |
| Dec 2023 | 2,566,500,000 | 314,900,000 | -100,200,000 | 6,605,100,000 | 2,431,200,000 | 4,173,900,000 | 275,700,000 |
| Dec 2022 | 2,569,100,000 | 343,200,000 | 243,100,000 | 6,587,000,000 | 2,380,100,000 | 4,206,900,000 | 182,700,000 |
TTM Snapshot
Revenues TTM
$2,480,300,000
NetIncome TTM
$95,300,000
OpCashFlow TTM
$0
Assets (Latest)
$5,679,000,000
Forward EPS
$1.67
Max Pain — expiry 2026-12-18
max pain strike: $25.00 · spot: $23.70 · call oi: 6,648 · put oi: 6,523Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLSE | PULSE BIOSCIENCES, INC. | $3.68B | $51.63 | — |
| IRTC | iRhythm Holdings, Inc. | $3.64B | $110.38 | — |
| ICUI | ICU MEDICAL INC/DE | $4.12B | $164.95 | — |
| LIVN | LivaNova PLC | $4.21B | $76.63 | — |
| HTFL | Heartflow, Inc. | $4.28B | $49.17 | — |
News headlines (Yahoo Finance, 1h cache)
NVST vs. ABT: Which Stock Is the Better Value Option?
2026-09-25 14:40 · Yahoo
Envista Holdings (NVST), Why Is Investor Attention Building Now?
2026-09-21 23:16 · Yahoo
Should Value Investors Buy Envista (NVST) Stock?
2026-09-18 13:40 · Yahoo
NVST or ABT: Which Is the Better Value Stock Right Now?
2026-09-09 15:40 · Yahoo
Envista Announces Participation in Baird 2026 Global Healthcare Conference
2026-09-08 20:10 · Yahoo
Envista Holdings Shares Rise After JPMorgan Upgrade
2026-09-03 13:45 · Yahoo
Envista (NVST) Stock May Be 42% Undervalued On Cash Flow
2026-09-02 14:11 · Yahoo
Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls
2026-09-03 13:31 · Yahoo
New Strong Buy Stocks for September 28th
2026-09-28 08:00 · Yahoo
Best Value Stocks to Buy for September 21st
2026-09-21 10:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.